6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of August, 2017

Commission File Number 1-14840

AMDOCS LIMITED

Hirzel House, Smith Street,

St. Peter Port, Island of Guernsey, GY1 2NG

Amdocs, Inc.

1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

FORM 20-F  ☒            FORM 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

YES  ☐            NO  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-                 

On August 2, 2017, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended June 30, 2017. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.

The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMDOCS LIMITED
By:	/s/ Matthew E. Smith
	Matthew E. Smith
	Secretary and Authorized Signatory

Date: August 2, 2017

EXHIBIT INDEX

EXHIBIT NO.	DESCRIPTION
99.1	Amdocs Limited Press Release dated August 2, 2017.

EX-99.1

Exhibit 99.1

Amdocs Limited Reports Third Quarter Fiscal 2017 Results

Record Quarterly Revenue of $967M

Expects Fiscal 2017 Revenue Growth of 3.5-4.5% YoY in Constant Currency

Expects Fiscal 2017 Non-GAAP Diluted EPS Growth Outlook of 5.5-7.5% YoY

Third Quarter Fiscal 2017 Highlights

• Revenue of $967 million, slightly above the midpoint of the $945-$985 million guidance range

• Diluted GAAP EPS of $0.81, above the $0.69-$0.77 guidance range, including the benefit of a lower GAAP effective tax rate

• Diluted non-GAAP EPS of $1.02, above the $0.93-$0.99 guidance range, including the benefit of a lower non-GAAP effective tax rate

• GAAP operating income of $130 million; GAAP operating margin of 13.4%

• Non-GAAP operating income of $167 million; non-GAAP operating margin of 17.3%

• Free cash flow of $134 million, comprised of cash flow from operations of $162 million, less $28 million in net capital expenditures and other

• Twelve-month backlog of $3.22 billion, up $10 million sequentially

• Quarterly cash dividend of $0.22 per share to be paid on October 20, 2017

ST. LOUIS – August 2, 2017 – Amdocs Limited (NASDAQ: DOX) today reported operating results for the three months ended June 30, 2017.

“We delivered a solid performance in Q3 which included another quarter of record revenue and our highest level of profitability in recent years. North America was strong as we supported the strategic initiatives of our customers in areas such as digital transformation,

Pay TV, network virtualization, and the enterprise segment. In Europe and Rest of World, we remained focused on our execution as we continued to progress several high-end projects towards production on behalf of some of the world’s largest service providers,” said Eli Gelman, president and chief executive officer of Amdocs Management Limited.

Gelman continued, “Our sales momentum was also strong in Q3 as we sustained a high win rate that included some important contract renewals, as well as several key awards in highly strategic areas. Among the highlights, I am pleased to report that we secured a significant enterprise B2B award with a new customer in the North American Pay TV market, and a definitive agreement with Australia’s Telstra to deploy an order orchestration and fulfillment solution that will help to transform the experience of their consumer and business customers.”

Gelman concluded, “We are encouraged by our strong sales momentum in the last several quarters which we believe indicates our ability to predict and invest in the future requirements of service providers, often many quarters in advance of their needs. Of course, we are closely monitoring the many moving parts affecting our near term outlook but with our year-to-date financial performance and the visibility of our record 12-month backlog we enter Q4 on track to deliver expected total returns to our shareholders in the mid-to-high single digits in fiscal 2017.”

Revenue

Revenue for the third fiscal quarter ended June 30, 2017 was $966.7 million, up 0.1% or $0.7 million sequentially from the second fiscal quarter of 2017 and up 3.9% as compared to last year’s third fiscal quarter. Revenue for the third fiscal quarter of 2017 includes a small positive impact from foreign currency movements of approximately $3 million relative to the second quarter of fiscal 2017. Revenue was at the midpoint of Amdocs’ guidance, excluding foreign currency movements.

Net Income and Earnings Per Share

The Company’s GAAP net income for the third quarter of fiscal 2017 was $119.3 million, or $0.81 per diluted share, compared to GAAP net income of $105.1 million, or $0.70 per diluted share, in the prior fiscal year’s third quarter. Net income on a non-GAAP basis was $150.4 million, or $1.02 per diluted share, compared to non-GAAP net income of $135.6 million, or $0.90 per diluted share, in the third quarter of fiscal 2016.

Returning Cash to Shareholders

• Quarterly Cash Dividend Program: On August 2, 2017, the Board approved the Company’s next quarterly cash dividend payment of $0.22 per share and set September 29, 2017 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on October 20, 2017.

• Share Repurchase Activity: Repurchased $90 million of ordinary shares during the third quarter of fiscal 2017.

Twelve-month Backlog

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.22 billion at the end of the third quarter of fiscal 2017, up $10 million from the end of the prior quarter.

Fourth Quarter fiscal 2017 Outlook

• Revenue of approximately $955-$995 million, including an immaterial sequential impact from foreign currency fluctuations as compared to the third quarter of fiscal 2017

• Diluted GAAP EPS of approximately $0.68-$0.76

• Diluted non-GAAP EPS of approximately $0.91-$0.97, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.06-$0.07 per share of equity-based compensation expense, net of related tax effects. This range reflects a non-GAAP effective tax rate in the fourth fiscal quarter above our annual target range of 13% to 17%

Full Year Fiscal 2017 Outlook

• Expects revenue growth of 3.5-4.5% year-over-year on a constant currency basis compared with previous guidance of 3.5-5.5% year-over-year

• Expects revenue growth of 3.5-4.5% year-over-year as reported compared with previous guidance of 3.0-5.0% year-over-year

• GAAP diluted earnings per share growth of roughly 7.0-10.0% year-over-year

• Non-GAAP diluted earnings per share growth of roughly 5.5-7.5% year-over-year compared with previous guidance of 4.5-8.5% year-over-year

Our fourth fiscal quarter 2017 and full year fiscal 2017 outlook takes into consideration the company’s expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, Amdocs notes market dynamics continue to shift rapidly and that it cannot predict all possible outcomes, including those resulting from AT&T’s proposed merger with Time Warner, the reported strategic discussions between Comcast, Charter and Sprint, or from other current and potential customer consolidation activity in North America.

Conference Call Details

Amdocs will host a conference call on August 2, 2017 at 5:00 p.m. Eastern Time to discuss the Company’s third quarter of fiscal 2017 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 43007164. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

• amortization of purchased intangible assets and other acquisition-related costs;

• changes in fair value of certain acquisition-related liabilities;

• equity-based compensation expense; and

• tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In

addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

• Keep up with Amdocs news by visiting the company’s website

• Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube

About Amdocs

Amdocs is a leading software and services provider to the world’s most successful communications and media companies. As our customers reinvent themselves, we enable their digital and network transformation through innovative solutions, delivery expertise and intelligent operations. Amdocs and its 25,000 employees serve customers in over 85 countries. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $3.7 billion in fiscal 2016.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters.

Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2016 filed on December 12, 2016 and our Form 6-K furnished for the first quarter of fiscal 2017 on February 13, 2017 and for the second quarter of fiscal 2017 on May 22, 2017.

Contact:

Matthew Smith

Head of Investor Relations

Amdocs

314-212-8328

E-mail: dox_info@amdocs.com

AMDOCS LIMITED

Consolidated Statements of Income

(In thousands, except per share data)

	Three months ended				Nine months ended
	June 30,				June 30,
	2017		2016		2017			2016
Revenue	$	966,695	$	930,133	$	2,887,431		$	2,777,573
Operating expenses:
Cost of revenue		628,640		601,249		1,871,211			1,796,933
Research and development		67,118		65,051		194,411			191,249
Selling, general and administrative		113,997		113,831		352,541			347,853
Amortization of purchased intangible assets and other		27,028		25,040		83,982			76,894
		836,783		805,171		2,502,145			2,412,929
Operating income		129,912		124,962		385,286			364,644
Interest and other income (expense), net		1,152		1,113		(2,079	)		908
Income before income taxes		131,064		126,075		383,207			365,552
Income taxes		11,800		21,015		53,590			51,930
Net income	$	119,264	$	105,060	$	329,617		$	313,622
Basic earnings per share	$	0.82	$	0.71	$	2.25		$	2.09
Diluted earnings per share	$	0.81	$	0.70	$	2.23		$	2.06
Basic weighted average number of shares outstanding		145,904		148,844		146,439			149,802
Diluted weighted average number of shares outstanding		147,259		150,726		147,865			151,912
Cash dividends declared per share	$	0.220	$	0.195	$	0.635		$	0.560

AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)

	Three months ended				Nine months ended
	June 30,				June 30,
	2017		2016		2017		2016
Revenue	$	966,695	$	930,133	$	2,887,431	$	2,777,573
Non-GAAP operating income		167,193		159,814		497,275		474,636
Non-GAAP net income		150,440		135,571		423,171		407,756
Non-GAAP diluted earnings per share	$	1.02	$	0.90	$	2.86	$	2.68
Diluted weighted average number of shares outstanding		147,259		150,726		147,865		151,912

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

	Three months ended June 30, 2017
			Reconciliation items
	GAAP		Amortization of purchased intangible assets and other			Equity based compensation expense			Tax effect			Non-GAAP
Operating expenses:
Cost of revenue	$	628,640	$	—		$	(4,763	)	$	—		$	623,877
Research and development		67,118		—			(914	)		—			66,204
Selling, general and administrative		113,997		—			(4,576	)		—			109,421
Amortization of purchased intangible assets and other		27,028		(27,028	)		—			—			—
Total operating expenses		836,783		(27,028	)		(10,253	)		—			799,502
Operating income		129,912		27,028			10,253			—			167,193
Income taxes		11,800		—			—			6,105			17,905
Net income	$	119,264	$	27,028		$	10,253		$	(6,105	)	$	150,440
	Three months ended June 30, 2016
			Reconciliation items
	GAAP		Amortization of purchased intangible assets and other			Equity based compensation expense			Tax effect			Non-GAAP
Operating expenses:
Cost of revenue	$	601,249	$	—		$	(4,406	)	$	—		$	596,843
Research and development		65,051		—			(953	)		—			64,098
Selling, general and administrative		113,831		—			(4,453	)		—			109,378
Amortization of purchased intangible assets and other		25,040		(25,040	)		—			—			—
Total operating expenses		805,171		(25,040	)		(9,812	)		—			770,319
Operating income		124,962		25,040			9,812			—			159,814
Income taxes		21,015		—			—			4,341			25,356
Net income	$	105,060	$	25,040		$	9,812		$	(4,341	)	$	135,571

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

	Nine months ended June 30, 2017
			Reconciliation items
	GAAP		Amortization of purchased intangible assets and other			Equity based compensation expense			Changes in fair value of certain acquisition- related liabilities			Tax effect			Non-GAAP
Operating expenses:
Cost of revenue	$	1,871,211	$	—		$	(14,734	)	$	6,691		$	—		$	1,863,168
Research and development		194,411		—			(2,714	)		—			—			191,697
Selling, general and administrative		352,541		—			(17,250	)		—			—			335,291
Amortization of purchased intangible assets and other		83,982		(83,982	)		—			—			—			—
Total operating expenses		2,502,145		(83,982	)		(34,698	)		6,691			—			2,390,156
Operating income		385,286		83,982			34,698			(6,691	)		—			497,275
Income taxes		53,590		—			—			—			18,435			72,025
Net income	$	329,617	$	83,982		$	34,698		$	(6,691	)	$	(18,435	)	$	423,171

	Nine months ended June 30, 2016
			Reconciliation items
	GAAP		Amortization of purchased intangible assets and other			Equity based compensation expense			Tax effect			Non-GAAP
Operating expenses:
Cost of revenue	$	1,796,933	$	—		$	(13,447	)	$	—		$	1,783,486
Research and development		191,249		—			(2,813	)		—			188,436
Selling, general and administrative		347,853		—			(16,838	)		—			331,015
Amortization of purchased intangible assets and other		76,894		(76,894	)		—			—			—
Total operating expenses		2,412,929		(76,894	)		(33,098	)		—			2,302,937
Operating income		364,644		76,894			33,098			—			474,636
Income taxes		51,930		—			—			15,858			67,788
Net income	$	313,622	$	76,894		$	33,098		$	(15,858	)	$	407,756

AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(in thousands)

	As of
	June 30, 2017		September 30, 2016
ASSETS
Current assets
Cash, cash equivalents and short-term interest-bearing investments	$	963,039	$	1,095,723
Accounts receivable, net, including unbilled of $174,898 and $134,122, respectively		893,386		818,531
Prepaid expenses and other current assets		228,611		186,137
Total current assets		2,085,036		2,100,391
Equipment and leasehold improvements, net		336,791		331,728
Goodwill and other intangible assets, net		2,395,253		2,493,166
Other noncurrent assets		476,537		406,070
Total assets	$	5,293,617	$	5,331,355
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable, accruals and other	$	1,053,303	$	992,679
Short-term financing arrangements		—		200,000
Deferred revenue		123,866		173,331
Total current liabilities		1,177,169		1,366,010
Other noncurrent liabilities		534,759		511,784
Shareholders’ equity		3,581,689		3,453,561
Total liabilities and shareholders’ equity	$	5,293,617	$	5,331,355

AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)

	Nine months ended June 30,
	2017			2016
Cash Flow from Operating Activities:
Net income	$	329,617		$	313,622
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization		163,533			159,792
Equity-based compensation expense		34,698			33,098
Deferred income taxes		7,201			(14,254	)
Excess tax benefit from equity-based compensation		(3,716	)		(5,682	)
(Gain) loss from short-term interest-bearing investments		(144	)		294
Net changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable		(73,033	)		(4,163	)
Prepaid expenses and other current assets		(1,258	)		(21,423	)
Other noncurrent assets		(60,949	)		11,070
Accounts payable, accrued expenses and accrued personnel		75,178			37,261
Deferred revenue		(38,817	)		(68,749	)
Income taxes payable		(7,726	)		12,263
Other noncurrent liabilities		12,520			14,397
Net cash provided by operating activities		437,104			467,526
Cash Flow from Investing Activities:
Payments for purchase of equipment and leasehold improvements, net		(98,565	)		(101,372	)
Proceeds from sale of short-term interest-bearing investments		218,395			264,357
Purchase of short-term interest-bearing investments		(218,772	)		(269,143	)
Net cash paid for acquisitions		—			(24,993	)
Other		(10,022	)		(20,109	)
Net cash used in investing activities		(108,964	)		(151,260	)
Cash Flow from Financing Activities:
Borrowings under financing arrangements		200,000			—
Payments under financing arrangements		(400,000	)		(220,000	)
Repurchase of shares		(250,231	)		(323,751	)
Proceeds from employee stock options exercised		75,763			67,890
Payments of dividends		(89,522	)		(80,468	)
Excess tax benefit from equity-based compensation and other		3,716			5,677
Net cash used in financing activities		(460,274	)		(550,652	)
Net decrease in cash and cash equivalents		(132,134	)		(234,386	)
Cash and cash equivalents at beginning of period		768,660			1,035,573
Cash and cash equivalents at end of period	$	636,526		$	801,187

AMDOCS LIMITED

Supplementary Information

(in millions)

	Three months ended
	June 30, 2017		March 31, 2017		December 31, 2016		September 30, 2016		June 30, 2016
North America	$	637.9	$	636.3	$	628.0	$	626.2	$	591.8
Europe		125.2		115.4		118.5		118.9		126.3
Rest of the World		203.6		214.3		208.2		195.6		212.0
Total Revenue	$	966.7	$	966.0	$	954.7	$	940.7	$	930.1

	Three months ended
	June 30, 2017		March 31, 2017		December 31, 2016		September 30, 2016		June 30, 2016
Managed Services Revenue	$	496.3	$	511.1	$	494.2	$	478.5	$	479.2

	Three months ended
	June 30, 2017		March 31, 2017		December 31, 2016		September 30, 2016		June 30, 2016
Customer Experience Systems	$	954.8	$	948.6	$	937.9	$	924.9	$	908.1
Directory		11.9		17.4		16.8		15.8		22.0
Total Revenue	$	966.7	$	966.0	$	954.7	$	940.7	$	930.1

	As of
	June 30, 2017		March 31, 2017		December 31, 2016		September 30, 2016		June 30, 2016
12-Month Backlog	$	3,220	$	3,210	$	3,180	$	3,170	$	3,110

# # #